Geminin as A Molecular Target for the Development of New Anticancer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|6|4|461-462

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.6, Iss.4, 2006-04, pp. : 461-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RNase P: A Promising Molecular Target for the Development of New Drugs

By  

Current Medicinal Chemistry, Vol. 11, Iss. 22, 2004-11 ,pp. : 2979-2989

Bentham Science Publishers

Access to resources Recommend Favorite

Neurogenesis as a New Target for the Development of Antidepressant Drugs

By  

Current Pharmaceutical Design, Vol. 20, Iss. 23, 2014-05 ,pp. : 3763-3775

Bentham Science Publishers

Access to resources Recommend Favorite

Methods for Elucidation of DNA-Anticancer Drug Interactions and their Applications in the Development of New Drugs

By  

Current Pharmaceutical Design, Vol. 22, Iss. 44, 2017-01 ,pp. : 6596-6611

Bentham Science Publishers

Access to resources Recommend Favorite

The brain as a target for development of new class of drugs for the treatment of somatic diseases

By Mravec Boris  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 433-437

Informa Healthcare

Access to resources Recommend Favorite

The MEP Pathway: A New Target for the Development of Herbicides, Antibiotics and Antimalarial Drugs

By  

Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. : 2391-2400

Bentham Science Publishers

Access to resources Recommend Favorite